Search clinical trials for: KMRC011 10μg or Placebo

Total 970 results

Hanmi Pharmaceutical Company Limited

Completed

A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese Subjects (EPO)

Healthy

United States
Centrexion Therapeutics

Completed

Safety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDN

Painful Diabetic Neuropathy

United States
Yale University
Johns Hopkins University; University of Colorado, Denver; Northwestern University and other collaborators

Recruiting

Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp (PREGnant)

Infertility | Endometriosis

United States
Reata, a wholly owned subsidiary of Biogen

Completed

A Study of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of RTA 901 in Healthy Adults

Healthy

United States
Pfenex, Inc
Department of Health and Human Services

Completed

A Study of Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects

Anthrax

United States
Hanmi Pharmaceutical Company Limited

Completed

A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean Subjects

Healthy

Korea, Republic of
International AIDS Vaccine Initiative
Beth Israel Deaconess Medical Center; Ragon Institute of MGH, MIT and Harvard; University of Texas Health, Houston AIDS Research Team (HART) and other collaborators

Completed

A Clinical Trial of PGDM1400 and PGT121 and VRC07-523LS Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults

HIV Infections

United States
Alex Pinto

Completed

Impact of Fruit and Vegetables in PKU

Phenylketonurias

United Kingdom
GlaxoSmithKline

Completed

Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)

Depressive Disorder

Korea, Republic of, Japan
Biosergen AS
Nucleus Network Ltd; Select Pharma Pty Ltd; Greenlight Clinical

Recruiting

A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005.

Invasive Fungal Infections

Australia
Boehringer Ingelheim

Completed

Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male Subjects

Healthy

Germany
Rezolute

Recruiting

RZ358 Treatment for Congenital Hyperinsulinism (sunRIZE)

Congenital Hyperinsulinism

Bulgaria, Canada, Denmark, France, Georgia, Germany, Greece, Israel, Oman, Qatar, Saudi Arabia, Spain, Turkey, United Arab Emirates, United Kingdom, Vietnam
King Faisal Hospital Rwanda

Not yet recruiting

Addressing Asymptomatic Plasmodium Reservoirs to Accelerate Malaria Elimination and Eradication in Rwanda.

Malaria,Falciparum
PhaseBio Pharmaceuticals Inc.

Completed

Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States
Turku University Hospital

Recruiting

The Optimal Route of Fecal Microbiota Transplantation for Irritable Bowel Syndrome

IBS - Irritable Bowel Syndrome | Microbial Substitution

Finland
Medical University of Vienna

Recruiting

Trial to Investigate the Effect of Dapagliflozin on Ischemia Reperfusion Induced Endothelial Dysfunction

Reperfusion Injury | Vascular Complications

Austria
AstraZeneca

Completed

A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia. (HARMONIZE Asia)

Hyperkalemia

China
University School of Physical Education, Krakow...
University of Bergen

Completed

Impact of Beetroot Supplementation in Athletes

Healthy

Poland
Immunitor LLC
University of Stellenbosch; Lisichansk Regional Tuberculosis Dispensary; National... and other collaborators

Completed

TB Immunotherapy Trial With Heat-killed M. Vaccae (imm03)

Tuberculosis

Mongolia, Ukraine
MacroGenics
Eli Lilly and Company

Terminated

Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes (SUBCUE)

Type 1 Diabetes Mellitus
Chiesi Farmaceutici S.p.A.

Completed

Study to Evaluate Efficacy/Safety of 4 Doses of CHF5259 Via Dry Powder Inhaler (DPI) in Patients With COPD (GlycoNEXT)

Chronic Obstructive Pulmonary Disease (COPD)

Czechia, Germany, Hungary, Romania
Wockhardt
Quintiles, Inc.

Completed

MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy Adults

Healthy Subjects

United States
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A First-in-human, Single-ascending-dose Study of IBI3002 in Healthy Participants and Mild to Moderate Asthmatics

Asthma | Healthy Participants

Australia
The University of Texas Health Science Center at...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria

Diabetes Mellitus, Type 2

United States
The University of Texas Health Science Center,...
Michael J. Fox Foundation for Parkinson's Research

Completed

Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for iPD

Parkinson's Disease

United States
Chinese University of Hong Kong

Completed

Lipid-Lowering Effect and Hypotensive Effect of Shanzha Fruit Drink in Patients

Hypertension | Hyperlipidemia

Hong Kong
Navy General Hospital, Beijing
Xijing Hospital; Peking Union Medical College Hospital; Chinese PLA General Hospital and other collaborators

Unknown

WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease (WANICHD)

Coronary Artery Disease
Vigonvita Life Sciences

Completed

Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction.

Erectile Dysfunction

China
Shandong Provincial Hospital

Not yet recruiting

Henagliflozin's Impact on Prediabetes Remission

Glucose Metabolism Disorders | PreDiabetes | Prediabetic State | Type 2 Diabetes

China
Jiangsu Nhwa Pharmaceutical Co., Ltd.

Recruiting

A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects

Schizophrenia

China
Dompé Farmaceutici S.p.A
Cromsource

Completed

Study to Evaluate Safety, Tolerability & PK of rhNGF in Healthy Volunteers

Healthy Volunteers

United States
Endo Pharmaceuticals

Terminated

Long-term Follow-up Durability (Efficacy) Study of EN3835 for the Treatment of AC of the Shoulder (Frozen Shoulder)

Adhesive Capsulitis | Frozen Shoulder

United States
Novartis Pharmaceuticals

Terminated

A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

United States, United Kingdom, Germany, Hungary, Russian Federation, Taiwan, Belgium, Netherlands, Japan, Austria, Finland, Slovakia, Czechia, Canada, Iceland, Poland
Nivalis Therapeutics, Inc.

Completed

A Safety Study Evaluating N6022 in Multiple-Ascending Doses in Healthy Subjects

Healthy

United States
Yonsei University

Completed

Impact of Dapagliflozin on DIAstolic Dysfunction in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Korea, Republic of
Provention Bio, Inc.

Completed

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of PRV-3279 in Healthy Subjects (PREVAIL1)

Safety

United States
Xijing Hospital of Digestive Diseases

Unknown

Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis

Primary Biliary Cirrhosis

China
BioKier Inc.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effect of BKR-013 on Average Daily Glucose Levels

Type 2 Diabetes Mellitus

United States
Pfizer

Completed

Safety and Pharmacokinetic Study of PF-06651600 in Healthy Volunteers

Healthy

Belgium
Pfizer

Completed

A Single Dose Study Of PF-06678552 In Healthy Subjects

Healthy

Belgium
Pfizer

Completed

A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Oral Doses Of PF-06273340

PAIN

Belgium
Bristol-Myers Squibb

Terminated

Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)

Type 2 Diabetes Mellitus

Canada
University of Extremadura

Active, not recruiting

Physiological and Functional Effects of Percutaneous Neuromodulation vs Transcutaneous Neuromodulation

Stroke/Brain Attack

Spain
Université de Sherbrooke
CHU de Quebec-Universite Laval

Active, not recruiting

Modification of the COVID-19 Vaccine Response by an Intervention on the Intestinal Flora (PIRATES-COV)

COVID-19 | Vaccine Reaction | Elderly

Canada
Pfizer

Terminated

A Study To Investigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers

Healthy Volunteers

United States
Inmagene LLC

Completed

Evaluate IMG-007 in Healthy Participants

Healthy Participants

Australia
Pfizer

Completed

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

United States, Spain, Israel, Korea, Republic of, Russian Federation, Turkey, Czechia, Hungary, Italy, Poland, Bulgaria, Denmark, Germany, Serbia, Austria, Slovakia, Ukraine, Georgia, Romania
Haisco Pharmaceutical Group Co., Ltd.

Recruiting

HSK7653 in Chinese Patients With Impaired Glucose Tolerance

Impaired Glucose Tolerance

China
Beth Israel Deaconess Medical Center
Kaneka Medical America LLC

Completed

Ubiquinol (Reduced COQ10) for Patients With Sepsis

Sepsis

United States
LG Life Sciences

Completed

Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients

Hypertension

Korea, Republic of

Search clinical trials for: KMRC011 10μg or Placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations